Prof Michael Dickinson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
302 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
DOI: 10.1016/S0140-6736(26)00362-42026
Journal article
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
DOI: 10.1182/blood.20250323072026
Journal article
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.
DOI: 10.1182/bloodadvances.20260201232026
Journal article
Glofitamab monotherapy in patients with Richter's transformation: safety and efficacy from a phase 1 study.
DOI: 10.1182/bloodadvances.20250181592026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122022
Research grants (other domestic)
Novel Strategies to Predict and Monitor Response to CAR T-Cell Therapy in DLBCL
2019
Journal article
Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
DOI: 10.1111/bjh.16069
RECENT SCHOLARLY WORKS
2026
Journal article
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries
DOI: 10.1182/blood.20250308722026
Journal article
Preparing Nurses for CD20-CD3 Bispecific Antibody Treatment in Patients With Non-Hodgkin Lymphoma: A Scoping Review of Adverse Events and Management Strategies From Early Phase and Pivotal Trials
DOI: 10.1097/NCC.00000000000014192026
Journal article
Web-Based Cognitive Rehabilitation for Patients With Aggressive Lymphoma With Perceived Cognitive Impairment: A Randomised Pilot Study
DOI: 10.1002/pon.704692026
Journal article
Five-Year Update of the Phase 2 ELARA Trial of Tisagenlecleucel in Patients (pts) with relapsed/refractory Follicular Lymphoma (r/r FL)
DOI: 10.1016/j.jtct.2025.12.0772026
Journal article
The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy
DOI: 10.1177/17562864251404464